Press release
Leading Generic Drug Manufacturers in World | By IMARC Group
Generic Drugs Brands
Generic drugs represent the bioequivalent of branded medicines with the same active ingredients and equivalent therapeutic effects. They also have similar risks, consequences, side effects, dosages, strengths, intended use, and route of administration. Generic drugs are relatively less expensive than branded medicines, as the production does not require extensive research. In addition, the production of these medications does not involve the repetition of clinical and animal studies to measure their effectiveness and safety. Generic drugs can be administered orally, dermally, or via injectables and inhalers. As a result, these medications are extensively available across retail and hospital pharmacies.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample
Generic Drugs Industry Growth:
The rising geriatric population and the escalating occurrence of chronic medical disorders across the globe, such as cancer, diabetes, and cardiovascular diseases, are among the primary factors driving the generic drugs market. Besides this, the changing dietary patterns, hectic schedules of individuals, and the launch of several policies by the government bodies to reduce healthcare costs and promote the manufacturing and uptake of these medications are further augmenting the market growth.
Moreover, the leading players, including Teva Pharmaceuticals, Mylan N.V., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Fresenius SE & Co., Lupin Limited, Endo Pharmaceuticals Inc., etc., are extensively investing in research and development (R&D) activities to engineer patent, effective, and safe food and drug administration (FDA)-approved medicines, which is also catalyzing the global market. Apart from this, the introduction of innovative technologies, such as nanoparticles, microchips, ultrasound-guided delivery, and microneedle patches, to enhance drug delivery methods is anticipated to propel the generic drugs market over the forecasted period.
Browse Full Report with TOC on Global Generic Drugs Market: https://www.imarcgroup.com/generic-drug-manufacturing-plant
Top 10 Generic Pharmaceutical Companies Worldwide:
1. Teva Pharmaceutical Industries Ltd.
Establishment:1901
Headquarters: Jerusalem, Israel
2. Mylan N.V.
Establishment:1961
Headquarters: Pennsylvania, United States
3. Novartis AG
Establishment:1996
Headquarters: Basel, Switzerland
4. Pfizer Inc.
Establishment:1849
Headquarters: New York, United States
5. Sun Pharmaceutical Industries Ltd.
Establishment:1983
Headquarters: Mumbai, India
6. Fresenius SE & Co.
Establishment:1912
Headquarter: Germany
7. Lupin Limited
Establishment:1968
Headquarters: Mumbai, India
8. Endo Pharmaceuticals Inc.
Establishment:1997
Headquarters: Pennsylvania, United States
9. Aurobindo Pharma Limited
Establishment:1986
Headquarters: Hyderabad, India
10. Aspen Pharmacare Holdings Limited
Establishment:1850
Headquarters: Durban, South Africa
Visit Full Blog: https://www.imarcgroup.com/generic-drug-manufacturing-companies
Browse More Research Reports:
• https://www.digitaljournal.com/pr/yogurt-market-size-to-reach-us-154-billion-by-2027-cagr-of-6-3
• https://www.digitaljournal.com/pr/automotive-piston-market-to-reach-us-4-91-billion-by-2027-cagr-of-3-1
• https://www.digitaljournal.com/pr/pickles-market-size-to-reach-us-14-1-billion-by-2027-cagr-of-4-05
• https://www.digitaljournal.com/pr/food-packaging-market-size-to-reach-us-483-4-billion-by-2027-cagr-of-5-85
• https://www.digitaljournal.com/pr/data-center-power-market-size-to-reach-us-29-8-billion-by-2027-cagr-of-6-4
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Generic Drug Manufacturers in World | By IMARC Group here
News-ID: 2941671 • Views: …
More Releases from IMARC Group
Green Tea Bags Manufacturing Plant DPR 2026: Investment Cost, Market Growth & RO …
Setting up a green tea bags manufacturing plant positions investors within one of the steadily expanding and health-oriented segments of the global beverage industry, driven by increasing consumer awareness of wellness, rising preference for natural antioxidants, and growing demand for convenient herbal drink options. Green tea is widely valued for its perceived health benefits, including metabolism support and antioxidant properties, making it popular among health-conscious urban populations.
The shift toward…
Calcium Acetate Prices Q4 2025: USA Reaches USD 1,165/MT While China Trades at U …
North America Calcium Acetate Price Outlook Q4 2025:
United States Calcium Acetate Price Overview:
In Q4 2025, calcium acetate prices in the United States reached USD 1165 per metric ton. The market remained firm due to steady demand from food processing, pharmaceuticals, and wastewater treatment sectors. Stable consumption patterns and moderate production costs supported pricing levels. Supply chain efficiency and consistent raw material availability helped prevent sharp fluctuations during the quarter.
Get the…
Automotive Radiator Manufacturing Plant DPR & Unit Setup - 2026: Demand Analysis …
Setting up an Automotive Radiator manufacturing plant positions investors in one of the most critical and high-demand segments of the global automotive components and thermal management industry, backed by sustained global growth driven by rising vehicle production, increasing regulatory focus on engine efficiency and emission reduction, and the growing adoption of electric and hybrid vehicles requiring advanced cooling solutions. As global automotive production expands across emerging economies, regulatory frameworks continue…
Watch Manufacturing Plant DPR & Unit Setup - 2026: Machinery, CapEx/OpEx, ROI an …
Setting up a watch manufacturing plant positions investors at the convergence of precision engineering, consumer lifestyle, luxury goods, and wearable technology - one of the most dynamic and diversified segments of the global consumer goods industry - driven by rising demand for luxury and premium accessories, increasing adoption of smart and hybrid watches, growing disposable incomes across emerging markets, and expanding e-commerce and organized retail channels enabling access to global…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
